GPT and steatosis: First, ALT serves as a well-established biomarker of hepatocellular injury and inflammation (13, 14); its elevation often precedes the onset of steatosis and reflects enhanced hepatic de novo lipogenesis (9, 22), which is frequently driven by excessive carbohydrate intake and insulin resistance (23, 24).